All Episodes
Lipid Luminations — 174 episodes
Treating Erectile Dysfunction: Key Cardiovascular Considerations
Pharmacometabolomics to Predict Statin Response: Ready for Prime Time?
Triglyceride-Lowering Therapies: Addressing Gaps in the Guidelines
PCSK9 Antibodies for Dyslipidemia: Efficacy, Safety, and Non-Lipid Effects
Canadian Perspectives on Managing Lipid Disorders in Children
Pathogenesis and Management of Non-Alcoholic Fatty Liver Disease
Lipid-Lowering Drug Interactions in Cardiovascular Agents
Selecting the Right Contraception for the Dyslipidemic Woman
Lipidologists Confronting the Obesity Epidemic: Perspectives from NLA President Joyce Ross
Big Data in Lipids: Refining Cardiovascular Risk Profiles Nationwide
Cardiovascular Risk Reduction in the Elderly: Best Lipid Strategies
What's the Deal with Saturated Fat and Cardiovascular Disease Risk?
Lipidology's Advances and Growing Pains: Technologies, Drug Trials, and Guidelines
The Lipidology Essentials: Making of a Specialty's Annual Summary
Recognition and Management of Mental Illness for the Non-Psychiatric Clinician
The Life and Times of LDL Cholesterol
Clinical Decisions on Cardiovascular Disease: Are Risks or Causes Your Guide?
Pathways Toward Better Lipid Medication Adherence
Special Populations in Patient-Centered Management of Dyslipidemia
Updated NLA Recommendations for African American Patients
Dyslipidemia in The Elderly: How Old is "Too Old" to Treat?
Dyslipidemia in Children and Adolescents
Guidelines for Diagnosis and Management of Dyslipidemia in Patients with HIV
Million Hearts Initiative with Dr. Janet Wright, Executive Director
Dyslipidemia During Pregnancy: The Risks for Two Patients
Statin Intolerance: Keys to Patient Counseling and Guidance
Roles of Non-HDL Cholesterol in Risk Assessment and Treatment
Keys to the Latest NLA Recommendations for Dyslipidemia Treatments
Management of the Patient With Triglycerides 200-499 mg/dl.
What is the Safety of Statins in Patients with Diabetes?
A Synopsis of the ACC/AHA Risk Assessment and Cholesterol Guidelines
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia
New Insights on Statin Therapy for Older Patients
HPS-2 THRIVE Data and Results
Health Information Technology's Impact on Adherence to Lipid Therapy
Cardiometabolic Consequences of Sitting Time
Generics and Manufacturing: What Prescribers Need to Know
Genetic Testing for Familial Hypercholesterolemia
Research Updates in Familial Hypercholesterolemia
Research Updates on Postprandial Dyslipidemia Treatment
Lipid Biomarker Updates: When to Move Beyond the Standard Profile
What is HoFH: Detection and Management of the Homozygous Familial Hypercholesterolemia (HoFH) Patient
Adiposity, Obesity, and Dyslipidemia
Researching Oxidized High-Density Lipoprotein in Obese Adolescents
Underrecognition of Diabetes in Cardiology Practice
An Avocado a Day: Does It Keep Heart Disease Away?
The Impact of Inflammation on HDL Activity
Changing Nutritional Needs Throughout the Lifetime
Managing CVD in Women During Childbearing Years
Obesity, Diabetes and the Metabolic Syndrome
Broken Hearts or Broken Bones?
Non-pharmacologic Approaches to the Metabolic Syndrome and Diabetes
Evolving Treatments: A Review of What’s in the Pipeline
Fish Oils: Are They Still Cardioprotective?
Treatment Options for Polycystic Ovarian Syndrome (PCOS)
Controversy Surrounding the NHLBI Pediatric Guidelines
Statin Safety Considerations
Emerging LDL Therapies
Emerging HDL Therapies: What’s Next on the Clinical Research Horizon
Understanding Why Patients Discontinue Statin Therapy
Statin Therapy and Diabetes Incidence
Lipids and Hormone Therapy
Diet Controversies in Lipid Lowering & Cardiovascular Disease Prevention
Biomarkers and Lipidology
Diagnosis, Prevalence, and Screening of Familial Hypercholesterolemia
Fat, Exercise and Cholesterol
Managing Lipids in the Chronic Kidney Disease Patient
Coronary CT Angiography
Genetic Testing to Improve Risk Assessment and Guide Therapies in Patients Facing Heart Disease
Management Issues in Familial Hypercholesterolemia
Familial Hypercholesterolemia: Risk Stratifications in Practice
From Experts to Analytics: What Does Evidence-Based Medicine Mean?
CIMT Appropriate Use Guidelines
Personalizing Dietary Approaches for Cardiovascular Health
LDL Apheresis
Imaging Guidelines for Screening CV Risk
Fundamentals of Fatty Acids
It's Relative: Screening and Treating Familial Hypercholesterolemia
Caring for Un- and Under-Insured Patients on Lipid Therapy
Current Inquiries in Lipidology: The NLA's Role in the Field
Predictive Value of Lipid Biomarkers and Inflammatory Markers
The Importance of Omega-3 Fatty Acids
Metabolic Syndrome in African Americans: Risk Adjustments & Treatments
Atherosclerosis and Cardiovascular Risk Factors in Children
Cardiometabolic Risk Reduction in Native Americans
The Process of Developing Clinical Guidelines
Updates on the ACCORD Trial From the 2010 National Lipid Association Meeting
Lipid Management and Systemic Approaches to Patient Care
Heart Disease in the United States: Past, Present, and Future Trends
Behavioral Strategies for Managing Weight
Exercise as Medicine
Using HDL in the Clinical Setting
Particle Number Testing in the Prevention of Atherosclerosis
Strategies to Help Reduce Diseases Associated with Lifestyle
Reevaluating Heart Protective vs Destructive Dietary Fats
Dietary Fats and Cardiovascular Disease
Pediatric Metabolic Syndrome
Trends in Stratifying Those With Cardiometabolic Risk
Finding Weight Loss Success in a Team-Based Approach
Keys to Weight Loss: Specific Nutrients or Just Calories?
Lipid Lowering: The End or the Means to Better CV Results?
Pursuing Ever More Accurate Cardiovascular Risk Projections
Keys to Reversing Pediatric Non-Alcoholic Fatty Liver Disease
Eating for Cardiovascular Health
A Critical View of JUPITER
Hormone Replacement Therapy and Heart Disease
NHANES Database Reveals Skyrocketing Triglyceride Levels
Carotid Ultrasound Scans for Assessing Cardiovascular Risk
Lowering Lipids Through Therapeutic Lifestyle Change
Good and Bad Dietary Fats Explained
Year in Review: Key Lipid Clinical Trials of 2008
JUPITER Study Shows Statins Help Even If Cholesterol Is Normal
Using Calcium Scoring for Cardiovascular Risk Prediction
Smoking Cessation Strategies for the 21st Century
Results of ADVANCE Diabetes Trial
The Importance of Non-HDL Cholesterol Testing
Cholesterol Management in Children
Analysis of the Interheart Study
High-Tech Cardiovascular Risk Assessment
Do Celebrity Heart Attacks Influence Public Health?
Connecting the Dots: Sleep Apnea and Heart Disease
Lifestyle Factors to Aid in Lowering Cholesterol
The ERA JUMP Study: Reevaluating the Omega-3 Index
Could Statins Protect Against Cognitive Decline?
Lipid-Lowering Effects of Thyroid Hormone
Looking Beyond LDL to Reduce Cardiovascular Events
Metabolic Syndrome in Children and Adolescents
Managing Insulin-Resistant Patients With Multiple Risk Factors
The Latest Targets of Lipid Therapy
Does ApoB Trump Non-HDL Measurements?
Polycystic Ovary Disease
LDL Apheresis
Advanced Cholesterol Testing
CVD Risk in Special Female Populations
The COURAGE Trial: Unpopular to Some, Embraced by Many
Impacting Atherosclerosis
The COURAGE Trial's Impact on Clinical Practice
CVD Risk Factors and Cognitive Impairment
Emerging Biomarkers and New Drugs
Misconceptions in Coronary Risk & Lipid Medicine
Advanced Coronary Risk Assessment Insights
CVD Risk Prediction
Atherosclerosis Imaging
Managing Statin Intolerant Patients
The ENHANCE Study
Accreditation Council for Clinical Lipidology
Diets, Lipids and Heart Disease
Managing Metabolic Syndrome
In and Around HDL
COURAGE Trial - Purpose and Design
COURAGE Trial in Hindsight
Who was John Gofman?
Oh Oh Omega 3!
Midwest Lipid Association Conference Series II
Midwest Lipid Association Conference Series I
The Lowdown on Lipid Lowering
Obesity: Identification, Evaluation and Treatment
Pediatric Obesity
Lipid Issues in the HIV Patient
Therapeutic Lifestyle Changes and Lipidology
Lipids and Other Markers
The Role of the Lipid Clinic & Cardiometabolic Risk
What About Subfractions?
Non-Statin Safety
Statin Safety
Diabetic Dyslipidemia
Combination Lipid Therapy... What Works?
Lipid Issues in Primary Care
Pediatric Dyslipidemia
OTC Supplement Discussion
Menopause and Lipidology
Cardiovascular Disease in Women
The ABCs of Preventing Heart Disease
Becoming a Full Time Lipidologist